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Summary 
 
Background 
Previous studies have reported national and regional Global Burden of Disease (GBD) estimates for 
the UK. Because of marked variation in health within the UK, action to improve it requires 
comparable estimates of disease burden and risks, at individual country and at local level. The recent 
slowdown in the rate of improvement in life expectancy is of concern and requires further 
investigation.  
Methods 
We estimated years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years 
(DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the 
UK, and 150 English Upper-Tier Local Authorities as part of the GBD Study 2016. We estimated the 
burden of disease by cause of death, condition, year, and sex. We analysed the relationship between 
burden of disease and socio-economic deprivation using the Index of Multiple Deprivation. 
Findings 
The leading causes of age-adjusted YLLs in all UK countries in 2016 were ischaemic heart disease, 
lung cancers, cerebrovascular disease, and chronic obstructive pulmonary disease. Age-standardised 
rates of YLLs for all causes combined varied two-fold between local areas in England according to 
levels of socio-economic deprivation (from 14,274 per 100,000 people in Blackpool [95% uncertainty 
interval 12,791–15,875] to 6,888 in Wokingham [6,145–7,739]). Some Upper-Tier Local Authorities, 
particularly in London, performed better than expected for their level of deprivation. Allowing for 
differences in age structure, more deprived Upper-Tier Local Authorities had higher attributable YLLs 
for most major risk factors in the GBD. The population attributable fractions for all-cause YLLs for 
individual major risk factors varied greatly across Upper-Tier Local Authorities.  
Life expectancy and YLLs have improved more slowly since 2010 in all UK countries. In 11 of 150 
Upper-Tier Local Authorities, YLLs increased after 2010. For attributable YLLs, the rate of 
improvement slowed most clearly for cardiovascular disease and certain cancers, and showed little 
change for dementia. 
Morbidity makes an increasing contribution to overall burden in the UK compared to mortality. The 
age-standardised UK DALY rate for low back and neck pain (1795 [1,258–2,356] per 100,000 per 
year) was higher than for ischaemic heart disease (1200 [1,155–1,246]) or lung cancer (660 [642-
679]). The leading causes of ill health (YLDs) in the UK in 2016 were low back and neck pain, skin and 
subcutaneous diseases, migraine, depressive disorders and sense organ disease. Age-standardised 
YLD rates varied much less than equivalent YLL rates across the UK but local data on causes of ill 
health are limited.  
Interpretation 
These estimates at local, regional, and national level allow policy makers to match resources and 
priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed 
notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are 
needed if the rate of improvement is to recover. A targeted policy response is also required to 
address the increasing proportion of burden due to morbidity, such as musculoskeletal problems 
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and depression. Improving the quality and completeness of available data on these causes is an 
essential component of this response. 
Funding Bill & Melinda Gates Foundation and Public Health England. 
 
Research in context 
Evidence before this study 
The Global Burden of Disease (GBD) Study has described the increasing contribution of non-fatal 
conditions to the burden of disease internationally and shown the importance of understanding 
geographic variations in disease, risk factors, and socio-economic deprivation. GBD has been used to 
generate subnational estimates in several countries to inform local priorities and practice. In the UK, 
policy and action to improve health requires comparable estimates of disease burden and risks at 
national and local authority level, but only regional estimates have been available from previous 
GBD rounds. Improvements in mortality are known to have slowed in the UK and other countries 
over a time scale that some have suggested implies a link with political, economic, and service 
factors in the UK. However similar changes have been seen in some other countries and the causes 
of the change in the UK remained unknown. The required policy response therefore remained 
uncertain. We know that sustained population level public health interventions can be effective and 
that benefits accrue both from prevention and improved treatment from health services. 
Added value of this study 
The contributions of individual conditions to years of life lost in the UK are quantified and compared 
for current policy-relevant geographies, the largest contributions being for ischaemic heart disease, 
lung cancers, cerebrovascular disease and chronic obstructive pulmonary disease. The extent to 
which the burden due to these conditions is attributed to specific potentially preventable risks is also 
quantified, including for example for tobacco use, poor diet, alcohol, obesity, and air pollution. 
Variation in burden between local areas is described and shown to relate strongly to levels of 
deprivation. Opportunity to reduce burden due to premature mortality by addressing specific risk 
factors is also shown to correlate strongly with deprivation. Non-fatal conditions are identified as 
increasingly important contributors to overall burden across the UK, particularly low back and neck 
pain, skin diseases, migraine, sense organ diseases, and depressive and anxiety disorders. 
Updated GBD estimates show that the slow-down in rate of improvement in overall mortality rates 
in the UK since 2010 appears to be condition specific and largely driven by slow-down in the rate of 
improvement in mortality from cardiovascular disease and certain cancers.  
Implications of all the available evidence 
The extent to which the UK could reduce the overall burden of fatal and non-fatal conditions 
through effective prevention is described and quantified. The results identify and rank potential 
local, regional, and national priorities for action that would reduce burden and provide relevant 
support for local and national advocacy on such priorities. They should be a direct input to long term 
planning for health, for example the current 10 year plan for the NHS in England. Social and 
economic determinants of ill health remain an overriding concern and there is clearly a need for 
economic development and regeneration of poorer parts of the country, as well as a need for high 
quality health improvement programmes and care services in these areas.  
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As mortality continues to reduce albeit more slowly than before, ill health due to low back pain, skin 
diseases, sense organ diseases, and depressive disorders makes an increasing contribution to overall 
burden of disease. Local estimates of levels of ill health currently used to guide policy and practice 
could be improved and made more comparable by better use of existing data. Health records and 
linkage to survey data should be used more extensively to refine disease prevalence estimates, 
improve consistency between GBD and other sources and provide more reliable data to guide policy 
and programmes to address these causes of ill health and their sequelae. 
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Introduction 
The Global Burden of Disease (GBD) project aims to produce the best possible comparable estimates 
of levels of ill health and injury around the world.1 It is an annual global assessment of the health of 
populations, broken down by age, sex, country, and selected subnational geographic areas.2-7 After 
20 years of refinement, it makes a unique contribution to health policy and practice worldwide. 8,9 
Previous studies have reported GBD 2010 estimates for the UK,10 and GBD 2013 estimates for nine 
English regions split by deprivation quintile.11 GBD estimates of burden of disease have been used 
extensively at national level, for example by Public Health England (PHE), an executive agency of the 
Department of Health and Social Care, in its strategic planning and in its national health profile 
report,12 and by Public Health Wales in its report Health and its Determinants in Wales,13 which in 
turn informed Public Health Wales’ strategic plan and also health service planning in Wales. The 
National Institute for Health Research has used GBD to assess the balance of their funded research 
portfolio.14 GBD has also been used at a more granular level by bodies with an interest in addressing 
high burden conditions such as mental health and musculoskeletal diseases, and by local Directors of 
Public Health.15 Scotland has recently undertaken its own independent burden of disease analysis.16 
Developing estimates of burden of disease for smaller geographic areas than whole countries 
(subnational estimates) to aid local policy and practice is a priority for the GBD project.17 In 2015, the 
UK11 and Japan18 were the first countries to publish subnational GBD estimates; India followed in 
2016,19 and subnational estimates have been presented for Brazil, Mexico, China, and the USA. 
Health policy is devolved in the UK and provision of services differs between the UK countries.20 In 
England, Upper-Tier Local Authorities  serving populations from 38,169 (Rutland) to 1,532,102 (Kent) 
have responsibility for maintaining and improving the health of their populations.21 Levels of 
deprivation vary markedly between Upper-Tier Local Authorities. Local autonomy and scarcity of 
resources for public health action together generate a requirement for national and local estimates 
of morbidity and mortality to inform priority setting for public health and health services.  
Several limitations of previous studies have been addressed through technical improvements and 
updates in GBD 2016. These include an expanded GBD cause hierarchy with 18 newly-specified 
causes of death and many new data sources. Updated GBD mortality information is of interest, as 
life expectancy improvement is known to have slowed in the UK and some other countries in recent 
years for reasons which remain unclear. It has been suggested that it could be due to reductions in 
welfare provision or even a systemic failure of social and health care in certain areas.22,23 It is 
important therefore to understand the nature of the change in more detail. 
This paper presents updated GBD 2016 estimates for the UK from 1990 to 2016 and for the first time 
includes results for 150 Upper-Tier Local Authorities  in England, as well as for England, Wales, 
Scotland, and Northern Ireland. These latest GBD results may help to explain the causes of the 
slowdown in life expectancy improvement since 2010, and are likely to be a guide to rational priority 
setting for health and social policy, prevention policy, health service planning, and research at 
national and local level.  
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Methods 
Life expectancy, years of life lost due to premature mortality (YLLs), years lived with disability (YLDs), 
disability-adjusted life-years (DALYs), and risk factors were estimated in the UK, England, Scotland, 
Wales, Northern Ireland, and 150 English Upper-Tier Local Authorities  from 1990 to 2016 for each 
location, age group, sex, and year. There are 152 Upper-Tier Local Authorities in England, including 
county councils, London boroughs, unitary authorities, and metropolitan districts. The City of 
London and Isles of Scilly were excluded from this analysis due to their small populations, and so 
data were available for 150 English Upper-Tier Local Authorities.  
Years of Life Lost and causes of death 
YLLs were computed by multiplying the number of estimated deaths by the standard life expectancy 
at age of death, derived from the lowest observed mortality rates in any population in the world 
greater than 5 million (86·6 years at birth for GBD 2016).2,4 Causes of death were mapped to the 264 
GBD 2016 causes of death and age and sex groups. Causes of death were organised in a four-level 
hierarchy which covered all deaths at all ages. The three cause groups at level one of this hierarchy 
were: communicable, maternal, neonatal, and nutritional diseases; non-communicable diseases; and 
injuries. These were broken down into level 2 causes with further disaggregation into level 3 and 4 
causes. Ischaemic stroke, for example, was classified as: non-communicable diseases (level 1); 
cardiovascular diseases (level 2); cerebrovascular disease (level 3); ischaemic stroke (level 4).3,4  
We compared causes of death at level 3 in the hierarchy to provide a meaningful level for policy 
makers and health professionals. The exception is cirrhosis, a GBD level 2 cause, which we show as a 
level 3 cause as further disaggregation into cirrhosis caused by hepatitis, alcohol, or other provides 
more granular detail than is required for comparison with other level 3 causes. Mortality was based 
on year of registration. In England and Wales, some deaths may be registered in subsequent years 
due to delays caused by coroners’ inquests, and some of this lag was taken into account in the 
modelling process, which smoothes over time. All imprecise causes of death, for example ill-defined 
cancer site or senility, were redistributed to the most likely alternative GBD cause of death.19 
Estimates for each location, year, age, and sex were then generated using a statistical method 
known as cause of death ensemble modelling (CODEm), which chose an ensemble of models that 
best reflected all the input data.3 The resulting estimates were rescaled so that the sum of all cause-
specific deaths equalled the total number of deaths from all causes in each age, sex, location, and 
year category.3 
Years Lived with a Disability 
YLDs were estimated by multiplying the prevalence of each cause and its consequences by a 
disability weight, corrected for comorbidity.4 The prevalence of each condition was estimated from 
published papers, unpublished documents, survey microdata, administrative records of health 
encounters, registries and disease surveillance systems. Data availability and use by GBD varied 
between countries. Data sources are available in Appendix Tables 1 to 5 for the different constituent 
nations in the UK for diabetes, chronic obstructive pulmonary disease, low back and neck pain, skin 
conditions and depression, and in full from the GBD Data Input Sources Tool.24 
DisMod-MR 2.1, a Bayesian meta-regression tool, was used to estimate YLDs whilst ensuring 
consistency between incidence, prevalence, remission, and cause of death rates for each 
condition.4,25 A first model was run on all the world’s GBD data which produced an initial global fit 
and estimated coefficients for predictor variables. The global fit was adjusted for predictors and 
passed down through the GBD geographic levels to country level and then to Upper-Tier Local 
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Authorities  in England in 2016. Disease-specific YLDs were adjusted for comorbidity. Estimates for 
locations with few or no data were predicted by borrowing information, for example on prevalence 
of a condition, from other locations, and using covariates to generate comparable estimates across 
all geographic locations.  
Maps of the UK were created for the changes in all-cause, age-standardised YLLs and YLDs over three 
time periods (1990–1999, 2000–2009, and 2010–2016), using UK census boundary data26 and 
geographic information software (ArcGIS).27 Deprivation in Upper-Tier Local Authorities was 
measured using the Index of Multiple Deprivation (IMD-2015), a composite measure estimated at 
small geographical areas, that includes seven domains: income, employment, education, health, 
crime, barriers to housing and services, and living environment.28 Correlations between IMD score 
and YLLs were calculated using Pearson’s correlation coefficients on a scale from +1 (perfect positive 
correlation) to -1 (perfect negative correlation), where scatter plots showed a linear relation.  
Disability-Adjusted Life Years 
DALYs are the sum of YLLs and YLDs for each location, age group, sex, and year.5 Risk factor exposure 
and attributable risk were estimated for 84 behavioural, environmental and occupational, and 
metabolic risks or clusters of risks.6 A total of 481 risk-outcome pairs met the GBD study criteria for 
convincing or probable evidence of a specific risk causing a specific outcome. The attributable 
burden for each risk was estimated by multiplying the YLLs and YLDs for each outcome of interest by 
the population attributable fraction (PAF) for the risk-outcome pair.6 The PAF represents the 
proportion of DALYs that would have been avoided in a given year if the exposure to a risk factor in 
the past had been at the theoretical minimum risk exposure level. 
Role of the funding source 
The GBD 2016 database development, methods improvement, and global analysis is primarily 
funded by the Bill & Melinda Gates Foundation, which had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. The corresponding author had full access 
to all data in the study and had final responsibility to submit the paper.  
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Results 
The leading causes of YLLs in the UK in 2016 for both sexes combined were ischaemic heart disease, 
trachea, bronchus and lung cancer (subsequently referred to as lung cancer), cerebrovascular 
disease, chronic obstructive pulmonary disease and dementia; the leading causes of disability (YLDs) 
were low back and neck pain, skin and subcutaneous diseases, migraine, depressive disorders, and 
sense organ diseases (Figure 1). The highest burden of age-standardised DALYs was for low back and 
neck pain (1795 [95% uncertainty interval 1,258–2,356] per 100,000 per year), followed by ischaemic 
heart disease (1200 [1,155–1,246]). In comparison, the DALY rate for lung cancer was 660 [642-679]. 
The all-cause age-standardised YLL rate in 2016 was highest in Scotland (11,195 [95% uncertainty 
interval 10,177-12,389] per 100,000 population) and lowest in England (8941 [8847-9028]), with 
ischaemic heart disease, lung cancer, cerebrovascular disease, and chronic obstructive pulmonary 
disease all particularly high in Scotland (Figure 1). Age-standardised YLDs were highest in England 
(11,054 [8211-14,261]) and Scotland (11,054 [8188-14,304]) and lowest in Wales (10,820 [8030-
14,039]), however the range of YLDs across the UK countries only varied by 234 per 100,000 per year 
compared to a range of 2254 per 100,000 per year for YLLs. England had high YLD rates for low back 
and neck pain, skin conditions and sense organ disease, and Northern Ireland had high rates for 
anxiety. 
Many conditions were important contributors to burden for both men and women but there were 
differences. For YLLs, men had higher rates for all ten leading conditions, except for dementia and 
breast cancer which had higher rates for women; ischaemic heart disease was the leading cause of 
YLLs in both men and women but the rate was approximately 2·5 times higher in men compared to 
women; self-harm was the third highest YLL rate for men, but was fourteenth highest for women 
(age-standardised YLL rate was 153 [95% uncertainty interval 146–162] for UK women in 2016 
compared to 546 [422–596] for men); prostate cancer and breast cancer were important causes of 
premature mortality for men and women, respectively, but breast cancer ranked higher for women 
than prostate cancer did for men. For YLDs, women had higher rates of disability for all the ten 
leading conditions, except for sense organ diseases, falls and drug use disorders, which were higher 
in men. 
The ten leading risk factors contributing to YLLs were similar in rank across the four countries of the 
UK (Figure 2). Although the ranks were similar, the PAF of each varied in size in different countries, 
such as a higher PAF from tobacco in Scotland, and from alcohol and drug use in Scotland and 
Northern Ireland compared to the other UK nations. 
In England in 2016, age-standardised rates of YLLs for all causes together varied more than two-fold 
between the highest and lowest IMD-ranked Upper-Tier Local Authorities (from 14,274 [12,791–
15,875] per 100,000 people in Blackpool to 6,888 [6,145–7,739] in Wokingham) (Figures 3 and 4). 
Comparing age-standardised YLL rates for the 15 (10%) most deprived and 15 least deprived Upper-
Tier Local Authorities in England (Figure 4), YLLs were markedly and consistently greater in the 
deprived areas for most conditions. The clearest association with deprivation was seen for all causes, 
lung cancer, and chronic obstructive pulmonary disease. No association was seen with conditions 
such as dementia, breast cancer, self-harm, and congenital defects (Appendix Table 6). Some Upper-
Tier Local Authorities performed better on YLLs than expected from their level of deprivation, 
including the London boroughs of Tower Hamlets and Hackney, and Birmingham (Figure 4). It was 
notable that Upper-Tier Local Authorities  in London had generally lower rates of DALYs and YLLs 
than expected for their level of deprivation throughout the distribution (Appendix Figures 1 and 2). 
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Variation in age-standardised YLD rates was much less marked than variation in YLLs, with no 
statistically significant variations (Figures 3 and 5 and Appendix Figure 3). .  
More deprived Upper-Tier Local Authorities had higher age-standardised attributable burden of age-
standardised all-cause YLLs than less deprived Upper-Tier Local Authorities for most risk factors, 
although there was variation within and between regions (Figure 6, Appendix Figure 4, and Appendix 
Figure 5). The PAF for risk factors also varied by Upper-Tier Local Authority for a given level of 
deprivation (Appendix Figure 6). For example, London Upper-Tier Local Authorities had lower than 
expected attributable YLL burden particularly for tobacco, dietary risks, and high body mass index, 
whereas the association between deprivation and alcohol and drug use, and occupational risks, 
showed less variation between regions. 
Between 1990 and 2016, life expectancy at birth for both men and women improved in all four UK 
countries, but the rate of improvement has slowed since 2010 (Figure 7). Although random variation 
is expected, 11 out of 150 English Upper-Tier Local Authorities experienced an increase in YLL rates 
since 2010 (Appendix Figure 7). The trends in annual change in age-standardised YLLs were however 
different when disaggregated by cause. The reduction in annual rate of improvement for all-cause 
YLLs since 2010 was driven by the gradual disappearance of what had been sustained annual 
improvements in YLL rates from ischaemic heart disease, cerebrovascular disease, and to a lesser 
extent colorectal cancer, lung cancer, and breast cancer (Figure 8). Dementia and chronic obstructive 
pulmonary disease showed no consistent trend in the rate of change over the period. The flattening 
of the improvement curve for cardiovascular disease deaths was seen in most age groups but was 
most apparent in those aged over 85 years, where previous improvements had been greatest 
(Appendix Figures 8 and 9). 
These cause-specific changes in YLL rates are reflected in the risk factor specific estimates of 
attributable burden. Annual reduction in all-cause age-standardised YLLs attributable to most major 
risk factors has also slowed since 2010, except for alcohol and drug use which has remained roughly 
unchanged since 2000 (Appendix Figure 10). The relation between rate of improvement in YLL and 
deprivation in Upper-Tier Local Authorities has shifted somewhat over time (Appendix Figures 11 
and 12). In the period up to 1999, improvement in YLLs were greatest in more affluent Upper-Tier 
Local Authorities (Pearson’s correlation coefficient r = 0·53); from 2000 to 2009, there was no overall 
relation between rate of improvement and deprivation; from 2010 to 2016, annual improvement 
has been greater in more deprived Upper-Tier Local Authorities (r = -0·50).  
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Discussion 
Burden of Disease across the UK 
The common causes of premature death in 2016 are similar in the four UK countries. However, 
premature mortality remains substantially higher in Scotland than in England, with higher rates for 
YLLs from all the leading ten causes, particularly cardiovascular disease, cancer, and cirrhosis. Wales 
and Northern Ireland have YLL rates in between those of England and Scotland, with some variation 
by cause. Comparison between UK countries at this level, however, masks substantial variation 
within those countries, for example between subnational geographical areas in Scotland29 and 
England.11 
Differences between UK countries are generally less for YLDs than for YLLs, with one notable 
exception being the high rates of YLDs for anxiety disorders in Northern Ireland. High levels of 
mental health conditions in Northern Ireland are acknowledged and have been attributed to the 
social and economic legacy of civil conflict.30,31 Across the countries of the UK, burden due to YLDs 
surpassed that due to YLLs in England in 2003, in Wales in 2008, and Northern Ireland in 2009, 
whereas in Scotland YLLs were similar to YLDs in 2016. As death rates fall, people live on with long 
term, often multiple, conditions, and YLDs rise. This pattern presents a considerable and familiar 
challenge to statutory health and care services. Finding a way of attenuating or mitigating the impact 
of this rising burden due to non-fatal conditions and the consequent demand for services must be 
the key to providing sustainable services in the future. 
Patterns shown in Figures 2 and 3 suggest that these long standing differences between the 
countries of the UK are likely to be substantially due to variations in risk factors and socio-economic 
deprivation rather than differences in health service organisation and spending. Public health policy 
and commissioning practices in England are different from those in Scotland, Wales and Northern 
Ireland, and health service spending has historically been lower in England, because of the different 
funding formulas adopted by the different nations in the UK.32-35 However, wider determinants of 
health such as employment opportunities, housing quality and availability, social cohesion and 
access to good quality education are likely to have a greater impact on health in localities than 
National Health Service (NHS) spend. 
Our results sometimes differ from the results of a recent study of burden of disease in Scotland, 
which used different data sources and methods reflecting its different purpose.16 For example, GBD 
calculated YLLs using the lowest observed mortality rates in the world and the World Standard 
Population (WSP). The Scottish burden of disease study used Scottish mortality rates and the 
European Standard population (ESP). The GBD method estimated a YLL rate for Scotland of 16,891 
compared to an estimate of 13,506 in the Scottish study.16,36 The Scottish study used local data to 
estimate YLD, resulting in different relative ranks for conditions and larger deprivation gradients in 
YLD than seen in the Upper-Tier Local Authority  analyses presented here.37 
English Upper-Tier Local Authority estimates 
These new local GBD estimates are a highly valuable resource, providing comparable detail down to 
local level that can support a range of local, regional and national actions. They are likely to be highly 
informative for regional transformation programmes currently embodied as Sustainability and 
Transformation Partnerships (STPs) and for developing Integrated Care Systems across England as 
the NHS in England delivers its 10-year long-term plan from 2019. They demonstrate the strong and 
persisting relationship between deprivation and premature mortality that varies by condition. 
Action, which may be local or national, is clearly essential to tackle the social and structural drivers 
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of ill health if overall health is to improve. Such action is feasible and can result in rapid 
improvements in health, with reductions in mortality potentially achievable within 1-2 years.38 
Population attributable fractions for major risks also vary considerably between areas, even within 
the same region. Individual area results such as these will be of interest to local public health leaders 
and should contribute to setting local priorities for action – recognising that such priorities can never 
be completely data driven and must reflect local opportunities, assets, and political will. Even for 
nationally important topics, locally specific data such as these GBD estimates make local advocacy 
more relevant and more persuasive for local policy makers.  
As described in previous GBD studies,11 London as a region has relatively low mortality for its level of 
deprivation.39 One explanation may be that London Upper-Tier Local Authorities have relatively low 
levels of risk factor exposures, particularly tobacco and dietary risks. Other possible factors are the 
high educational performance of poor children in London,40 and selective movement of sicker people 
out of London, and healthy younger migrants in for work. Access to health services in London may 
also be a factor, with some evidence that health services in the North East and North West of 
England are relatively underfunded compared to London.41 The low mortality may be at least partly 
an artefact related to inaccuracies in population estimates for London as a consequence of high 
population turnover, with high levels of internal and international migration. Finally, IMD scores may 
function differently in London, as for example the housing deprivation domain includes measure of 
housing affordability, for which London does particularly badly. 
Areas of socio-economic deprivation are present throughout the country but are concentrated in the 
large conurbations of the North.42 The GBD estimates by Upper-Tier Local Authority show that areas 
of London and Birmingham both have relatively low levels of attributable risk and YLLs compared to 
Upper-Tier Local Authorities with similar deprivation in the northern cities of Liverpool and 
Manchester. This further strengthens the need for specific action to respond to the set of distinct 
problems that exists in these northern cities.42,43 There are also important within-country ethnic 
differences in outcomes that are not considered in this analysis.44 
Local GBD data on YLDs are more difficult to evaluate as YLD rates are very similar for many 
important conditions across local areas. The most likely explanation for the large uncertainty around 
YLDs is the relative lack of local data on prevalence of the major causes of disability, resulting in 
estimates that are modelled from data on neighbouring areas. The wide uncertainty around 
disability weights also increases the uncertainty around YLDs. In comparison, YLLs are based on 
annual cause of death data from vital registration that show much less heterogeneity between 
locations and over time compared to non-fatal data sources. To guide an appropriate response, 
much better local data are needed on causes of disability. These could come from health care 
datasets, surveys, or other sources including covariates. However, utilisation data can be biased due 
to supply factors (such as unavailability for some populations) and surveys may be expensive.  
Trends in mortality 
Official mortality statistics show that the long-standing trend for annual improvement in life 
expectancy in England and Wales has slowed since 2011.45 Infant mortality rates have increased 
slightly since 2014, although they remain at historically low levels.46 The latest GBD results confirm 
this effect for YLLs in all the UK countries. As this change in trend has become established, it has 
generated considerable speculation about its cause or causes but little if any firm evidence. Watkins 
et al. found an apparent correlation with levels of total public spending on health and on social 
care.23 Hiam et al. suggested that in the absence of other plausible causes, cuts to the UK health and 
social care system were the most likely explanation.22 Marked fluctuations in numbers of deaths 
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from year to year, but not the overall trend, can often be attributed to levels of circulating flu.47 
Raleigh points out that many different factors are likely to be involved, including a cohort effect with 
the gains from reducing smoking already substantially realised, and the rise of comorbidity.48 A 
similar change seems to have occurred in a number of other countries at a similar time,47,49 which 
argues against economic or health service factors unique to the UK, and suggests something more 
fundamental is going on related to trends in demography, epidemiology, or socio-economic factors 
seen in a number of other countries. The new GBD data reported here show that the change in 
overall trend is mainly driven by a set of distinct condition-specific trends predominantly in 
cardiovascular diseases and some cancers. The worsening trend in YLLs to some cancers is a concern 
given evidence that survival for some common cancers is already worse in the UK than in some 
comparable countries.50 Population-level period factors such as the global economic crisis since 
2008, impact of fiscal austerity in the UK or the quality and capacity of local services could 
conceivably operate differentially on specific conditions through risk factor exposures, health care 
provision, or certain social determinants of health.51  
More affluent areas experienced greater annual mortality improvements before 2000, but this 
changed after 2010 when the national slowdown in mortality improvement was, counterintuitively, 
most marked in relatively affluent areas (Appendix Figures 7 and 11). This is a new finding and 
contrasts with evidence from some previous recessions that mortality rates tend to improve during 
economic downturns, perhaps due to declines in risky behaviours.43 The reasons for this slowdown 
in mortality improvement in less deprived areas are not clear, and further research is needed both 
into the relation between deprivation and mortality trends since 2010, and the many possible 
contributory factors before conclusions can be drawn. Changes in deprivation for older people, 
unemployment, and binge drinking have been shown to be important in explaining life expectancy 
differences.52 Together, these findings seem to suggest that the overall change in trend in YLLs is the 
result of an evolving epidemiological transition with multiple condition-specific and possibly cohort-
based components, including changing exposure to certain risk factors.  
Strengths and limitations 
Where data were not available for a particular location, GBD modelled estimates using data from 
other locations and predictive covariates. The availability of accurate local data on mortality was 
better than for morbidity, which may explain why the variation in YLD rates was much less marked 
across the UK than variation in YLLs. Data sources used to produce these 2016 estimates of YLD for 
the four UK countries for the example conditions of diabetes mellitus, chronic obstructive pulmonary 
disease, low back and neck pain, skin and subcutaneous diseases, and depressive disorders show 
that different sources were used for different locations, and therefore some of the variation 
reported may be due to different data sources rather than true underlying variation (Appendix 
Tables 1 to 5). A full list of data input sources for GBD 2016 is available elsewhere.24 
Where new data or changes in modelling lead to changes in estimates of disease burden, a strength 
of the GBD approach is that all previous estimates are recalculated using the newest model. For 
example, the apparent increase in skin disease in GBD 2016 compared to 2013 was due to a change 
in the method of estimating severity for acne, to award higher disability to a subset of cases with 
more severe disease, whereas in the past all cases were deemed to have mild disability,53 and 
inclusion of new, more accurate data for dermatitis.  
The decision to use a global, European, or UK-specific condition severity distribution affects YLD 
estimates. The data sources on variations in severity distribution by age or location are sparse; this is 
a limitation as one would expect substantial variation in severity for conditions for which effective 
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treatments exist. The way deprivation is measured varies across the four countries of the UK, but 
previous work by Public Health England suggests that this does not substantially affect the relation 
between deprivation and prevalence, at least for cancer.54 The relation between risk factors and 
outcomes may differ across areas, which may lead to underestimation or overestimation of 
attributable risk in some areas.55 
Diabetes mellitus, asthma, skin disease, and chronic obstructive pulmonary disease are examples of 
conditions where GBD and alternative UK estimates differ in 2016. These differences arise mainly 
from the use of different data sources and disease definitions, and partly from the methods used to 
model the data in GBD. For example, primary care electronic health record data in England (The 
Quality and Outcomes Framework and The Health Improvement Network) as well as reported data 
from the Health Survey for England all show a rising diabetes prevalence (consistent with other high-
income countries),56-58 whereas GBD used data from research papers for diabetes prevalence, which 
show a flat or falling prevalence rate.24 It has been difficult to reconcile these differences partly 
because data governance concerns prevent even anonymised records from UK primary care being 
made available to the GBD project. 
The choice of which GBD level to use when presenting results changes the rank order of conditions. 
We have presented results by level 3 conditions, which gives low back and neck pain and skin and 
subcutaneous diseases as the leading UK causes of YLDs. At level 2, musculoskeletal and mental 
disorders are the leading causes (appendix figure 13).3,4 The distinction between behavioural and 
metabolic risk factors (Figure 2) is not absolute, as behavioural factors such as physical activity and 
diet clearly affect metabolic factors such as high blood pressure and body mass index. 
Implications for research and policy 
The results overall strongly suggest that all countries of the UK could further reduce the burden of 
disease through effective prevention. For example, the continued dominance of cardiovascular 
disease in GBD argues for renewed efforts to deliver systematic programmes to reduce risk factors 
such as high body mass index, high fasting glucose, high blood pressure and high cholesterol. Other 
conditions that feature highly in GBD estimates for the UK such as cancers and respiratory disease 
can be addressed by tackling behaviours such as smoking and eating unhealthy foods. Good progress 
has been made in some areas, notably in reducing smoking rates to historic lows in all countries of 
the UK, but there is scope to do so much more in almost all areas of primary prevention. 
Overall, some two-thirds of improvements to date in premature mortality can be attributed to 
population-wide decreases in smoking, cholesterol, and blood pressure, and approximately one-
third due to improved therapies.59 Health services need to recognise therefore that prevention is a 
core activity rather than an optional extra to be undertaken if resources allow. In many cases of 
course, the causes of ill health and the behaviours that cause it lie outside the control of health 
services. For example, obesity, sedentary behaviour and excess alcohol use all feature strongly in 
GBD as risk factors for diseases such as musculo-skeletal disease, liver disease and poor mental 
health. The GBD results therefore also argue for policies and programmes that deter the food 
industry from a business model based on cheap calories, that promote and sustain healthy built and 
natural environments, and that encourage a heathy drinking culture.  
The same level of attention that has previously been given to prevention of cardiovascular disease 
and cancer now also needs to be directed at the other major causes of YLLs, such as liver disease and 
dementia, and associated risk factors including unhealthy diets, alcohol, air pollution, and drug 
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misuse. Unfortunately, adequate research on effective population-level prevention interventions in 
these areas is much more limited, but by no means absent.  
Public health policy needs also to respond actively and rapidly to the shift in relative burden from 
mortality towards morbidity. More evidence is needed to support population-level interventions to 
address the causes and effects of conditions such as musculoskeletal disease, poor mental health, 
and sensory impairments, and there is an urgent need for research and action to prevent further 
increases in burden due to disability from these conditions, and to understand the economic impact. 
Timely access to health services is important for treatable conditions such as vision loss caused by 
cataract, glaucoma, and diabetic retinopathy. The promotion of musculoskeletal and mental health 
are key components of the recent WHO Europe Action Plan for Noncommunicable Disease to avoid 
premature death and significantly reduce disease burden.60 
There are still concerns with the accuracy of local estimates of ill health, but the hierarchical ranking 
of YLD by Upper-Tier Local Authority can inform better local targeting of health services. For future 
iterations of GBD, the use of primary care electronic health records, including prescribing, should be 
used to refine disease prevalence estimates and improve consistency between GBD and other 
reliable estimates, while recognising that utilisation rates have known weaknesses as measures of 
need.61 Health care utilisation data remain underutilised for descriptive epidemiology. Their value 
can be greatly enhanced if linked to population survey data and death records where the strengths 
of each data type (good diagnostic information in health records; data on risk factors and severity of 
disease from surveys) enhance their value for population health measurement. There are excellent 
examples of data linkage for audit (for example the Sentinel Stroke National Audit programme), 
research (for example the Caliber project at University College London), and policy (for example 
NHSDigital linked hospital and mortality data), but still no linked health data that can inform 
comparable estimates of burden of disease at local level. Further research on disease burden at 
Upper-Tier Local Authority level should explore the burden of different diseases at a more specific 
level of diagnosis, and explore the impact of age disaggregation, for example in children and in 
different age groups for older people.  
Overall this study provides a timely input into the new long term plan for the NHS in England and 
similar planning processes both in the other countries of the UK, and at local level in England. The 
new local estimates will increase the relevance of GBD for many users, highlighting where local 
levels of burden and risk factors may require tailored local solutions, for example for diet and 
occupational risks (Appendix Figures 4, 5 and 6). National results reveal the need for effective 
primary prevention to reduce the substantial attributable risks due to smoking, unhealthy diets, 
obesity and excess alcohol use, which lead to massive burden from heart disease, cancer and the 
multiple co-existing conditions that reduce independence in older people. Resource allocation in 
health services needs to continually adapt to the increasing burden from non-fatal conditions such 
as musculoskeletal conditions, depressive disorders, sensory loss and skin diseases. Significant 
improvement in the quality and completeness of available morbidity data is needed to support 
implementation of such a change in national health policy. 
Finally, we hope that this study will inform similar analyses across Europe supported by the newly 
formed WHO European Burden of Disease Network.62  
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Figure 1: Age-standardised years of life lost (YLLs), years lived with disability (YLDs), and disability-
adjusted life years (DALYs) rate per 100,000 population for all causes combined and leading ten 
causes in UK countries, women, men, and both sexes combined, 2016 
 
 United 
Kingdom 
England Scotland Wales Northern 
Ireland 
Bo
th
 Y
LL
s 
All causes 9222 8941 11195 10080 10090 
Ischaemic heart disease 1099 1040 1457 1318 1344 
Trachea, bronchus, and lung cancer 649 623 856 701 699 
Cerebrovascular disease 452 431 630 485 501 
Chronic obstructive pulmonary 
disease 419 408 512 437 425 
Alzheimer's disease and other 
dementias 352 346 378 402 378 
Self-harm 349 326 507 410 495 
Lower respiratory infections 337 336 337 322 390 
Cirrhosis and other chronic liver 
diseases 318 302 460 349 294 
Colon and rectum cancer 295 286 338 337 338 
Breast cancer 276 271 303 302 288 
Fe
m
al
e 
YL
Ls
 
All causes 7365 7164 8839 7905 7750 
Ischaemic heart disease 610 570 862 747 773 
Trachea, bronchus, and lung cancer 541 516 757 571 543 
Breast cancer 526 517 572 576 548 
Cerebrovascular disease 401 380 567 433 449 
Alzheimer's disease and other 
dementias 368 361 393 415 390 
Chronic obstructive pulmonary 
disease 364 350 472 384 375 
Lower respiratory infections 283 282 279 278 328 
Colon and rectum cancer 234 227 275 255 263 
Congenital birth defects 224 221 216 233 312 
Cirrhosis and other chronic liver 
diseases 223 212 328 244 205 
M
al
e 
YL
Ls
 
All causes 11236 10864 13805 12423 12651 
Ischaemic heart disease 1637 1557 2129 1949 1986 
Trachea, bronchus, and lung cancer 772 743 976 847 878 
Self-harm 546 509 767 670 836 
Cerebrovascular disease 511 488 702 546 561 
Chronic obstructive pulmonary 
disease 489 479 570 506 495 
Cirrhosis and other chronic liver 
diseases 415 395 601 459 387 
Lower respiratory infections 404 402 411 377 472 
Colon and rectum cancer 363 352 410 428 422 
Alzheimer's disease and other 
dementias 323 317 352 379 355 
CONFIDENTIAL pre publication draft. Please do not cite or circulate 
22 
Prostate cancer 308 307 309 327 311 
Bo
th
 Y
LD
s 
All causes 11035 11054 11054 10820 10827 
Low back and neck pain 1795 1820 1654 1692 1645 
Skin and subcutaneous diseases 1036 1043 1003 989 977 
Migraine 732 719 809 785 786 
Depressive disorders 668 664 702 673 686 
Sense organ diseases 651 667 570 559 593 
Anxiety disorders 442 435 464 451 567 
Falls 364 364 374 357 361 
Oral disorders 354 355 353 347 347 
Asthma 354 348 397 368 371 
Other musculoskeletal disorders 322 323 317 317 295 
Fe
m
al
e 
YL
Ds
 
All causes 11741 11773 11667 11451 11546 
Low back and neck pain 2023 2056 1841 1885 1847 
Skin and subcutaneous diseases 1149 1158 1112 1095 1082 
Migraine 965 946 1086 1045 1043 
Depressive disorders 791 784 850 796 822 
Sense organ diseases 627 641 556 546 574 
Anxiety disorders 567 557 595 582 729 
Other musculoskeletal disorders 375 375 379 377 360 
Asthma 374 367 430 392 403 
Oral disorders 366 367 366 360 360 
Falls 325 326 333 315 308 
M
al
e 
YL
Ds
 
All causes 10324 10331 10421 10188 10093 
Low back and neck pain 1557 1576 1454 1491 1432 
Skin and subcutaneous diseases 923 930 893 884 870 
Sense organ diseases 678 695 587 574 615 
Depressive disorders 543 543 548 548 546 
Migraine 496 491 521 523 522 
Falls 400 399 411 397 413 
Drug use disorders 371 362 472 423 249 
Oral disorders 341 342 339 334 333 
Asthma 333 330 363 344 338 
Anxiety disorders 317 313 330 319 402 
Bo
th
 D
AL
Ys
 
All causes 20257 19995 22249 20900 20917 
Low back and neck pain 1795 1820 1654 1692 1645 
Ischaemic heart disease 1200 1139 1567 1428 1471 
Skin and subcutaneous diseases 1060 1068 1028 1012 999 
Migraine 732 719 809 785 786 
Depressive disorders 668 664 702 673 686 
Trachea, bronchus, and lung cancer 660 633 870 712 711 
Sense organ diseases 651 667 570 559 593 
Cerebrovascular disease 598 570 825 650 657 
Chronic obstructive pulmonary 
disease 519 507 618 533 521 
Drug use disorders 465 443 714 531 304 
Fe m
alAll causes 19106 18937 20506 19356 19296 
Low back and neck pain 2023 2056 1841 1885 1847 
CONFIDENTIAL pre publication draft. Please do not cite or circulate 
23 
Skin and subcutaneous diseases 1174 1184 1136 1118 1104 
Migraine 965 946 1086 1045 1043 
Depressive disorders 791 784 850 796 822 
Ischaemic heart disease 688 647 945 829 869 
Sense organ diseases 627 641 556 546 574 
Anxiety disorders 567 557 595 582 729 
Breast cancer 566 556 618 624 595 
Trachea, bronchus, and lung cancer 550 525 769 580 552 
Cerebrovascular disease 544 517 755 587 600 
M
al
e 
DA
LY
s 
All causes 21559 21195 24226 22611 22744 
Ischaemic heart disease 1763 1680 2268 2089 2147 
Low back and neck pain 1557 1576 1454 1491 1432 
Skin and subcutaneous diseases 946 953 917 907 892 
Trachea, bronchus, and lung cancer 785 755 992 860 892 
Sense organ diseases 678 695 587 574 615 
Cerebrovascular disease 661 631 909 724 724 
Drug use disorders 658 617 1118 789 389 
Chronic obstructive pulmonary 
disease 605 595 692 617 608 
Self-harm 554 517 775 678 844 
Depressive disorders 543 543 548 548 546 
 
 
  Significantly lower than UK mean (95%UI) 
  Significantly higher than UK mean (95%UI) 
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Figure 2: Population attributable fraction (PAF) for risk factors for all-cause years of life lost (YLLs) rate per 100,000 population for England, Scotland, Wales, 
and Northern Ireland, both sexes, 2016 
Rank England PAF (%)  Scotland PAF (%)  Wales PAF (%)  Northern Ireland PAF (%) 
1 Tobacco 19.26  Tobacco 22.76  Tobacco 20.31  Tobacco 20.01 
            
2 Dietary risks 14.41  Dietary risks 16.12  Dietary risks 16.35  Dietary risks 15.88 
            
3 High blood pressure 13.04  High blood pressure 14.62  High blood pressure 15.53  High blood pressure 14.99 
            
4 High body mass index 9.57  Alcohol and drug use 12.98  High body mass index 9.85  Alcohol and drug use 11.50 
            
5 Alcohol and drug use 9.52  High body mass index 10.70  Alcohol and drug use 9.59  High body mass index 9.97 
            
6 High total cholesterol 7.44  High total cholesterol 8.49  High total cholesterol 8.07  High total cholesterol 8.35 
            
7 Occupational risks 4.85  High fasting plasma glucose 5.02  High fasting plasma glucose 5.20  High fasting plasma glucose 5.18 
            
8 High fasting plasma glucose 4.84  Occupational risks 4.63  Occupational risks 4.55  Occupational risks 4.30 
            
9 Air pollution 4.04  Air pollution 3.87  Air pollution 3.91  Air pollution 3.58 
            
10 Low physical activity 2.16  Impaired kidney function 2.48  Low physical activity 2.03  Low physical activity 2.52 
 
 
 
Behavioural  Environmental and occupational  Metabolic  
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Figure 3. All-cause age-standardised years of life lost (YLLs) and years lived with disability (YLDs) rate per 100,000 population by UK country and English 
Upper Tier Local Authorities, 2016 
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Figure 4. Age-standardised years of life lost (YLLs) rate per 100,000 population for the 20 causes with the highest national YLL burden in order of decreasing 
burden, in the 15 (10%) most deprived and 15 (10%) least deprived Upper-Tier Local Authorities (UTLAs) in England, both sexes, 2016 
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Most deprived 15 
UTLAs                       
Blackpool 42 14274 1708 1012 718 761 570 359 742 665 429 374 359 264 293 301 286 234 355 211 225 170 
Kingston upon 
Hull, City of 41 11501 1448 1086 732 602 450 353 336 443 357 305 257 224 199 172 208 198 163 190 179 170 
Knowsley 41 11033 1379 1112 746 509 481 354 362 256 356 293 218 269 192 178 171 191 175 171 195 150 
Liverpool 41 11607 1268 1094 691 525 511 356 537 304 361 285 326 274 176 429 199 189 263 165 198 130 
Manchester 41 11729 1483 1045 738 598 468 353 531 316 343 275 345 241 147 352 240 192 267 150 186 124 
Middlesbrough 40 11693 1398 1073 670 629 494 355 413 415 396 310 271 223 209 164 193 201 200 224 171 144 
Birmingham 38 10369 1254 690 482 490 391 347 379 280 304 263 571 329 159 277 176 176 187 150 160 122 
Nottingham 37 11313 1337 876 635 533 420 353 421 364 352 305 417 359 171 146 229 206 209 183 176 151 
Tower Hamlets 36 9629 1186 849 560 392 332 334 338 226 268 219 286 218 124 354 186 184 174 138 136 126 
Barking and 
Dagenham 35 10617 1364 944 634 447 471 348 319 290 308 325 245 261 175 71 209 204 157 204 152 151 
Hackney 35 9388 1128 705 435 368 327 333 355 237 244 242 354 169 136 323 187 176 180 142 126 136 
Sandwell 35 10870 1346 791 563 559 407 355 405 331 327 306 418 351 193 124 192 193 196 165 168 132 
Blackburn with 
Darwen 34 11464 1619 806 671 595 436 357 378 436 351 271 357 231 211 269 181 186 183 179 196 171 
Rochdale 34 11150 1497 852 634 619 440 360 406 389 313 303 276 235 203 226 205 188 195 183 175 143 
Stoke-on-Trent 34 11847 1335 918 660 484 413 358 388 357 374 317 526 459 190 254 222 211 188 207 202 153 
England 
(95% uncertainty 
interval) NA 
8941 
(8847-
9029) 
1040 
(1018-
1071) 
623 
(608-
642) 
408 
(391-
445) 
431 
(407-
452) 
336 
(314-
356) 
345 
(296-
411) 
302 
(292-
312) 
326 
(278-
359) 
286 
(276-
298) 
271 
(261-
282) 
262 
(237-
273) 
238 
(224-
276) 
170 
(163-
180) 
167 
(152-
177) 
174 
(168-
180) 
170 
(165-
175) 
147 
(135-
159) 
149 
(143-
154) 
143 
(136-
149) 
139 
(112-
148) 
Least deprived 15 
UTLAs                       
Bath and North 
East Somerset 12 7512 807 459 262 358 263 343 223 290 258 234 147 249 138 120 154 158 108 138 127 156 
Central 
Bedfordshire 12 7798 895 527 361 348 299 342 221 262 260 248 143 202 184 118 155 151 107 131 133 137 
Hampshire 12 7438 790 474 298 360 269 340 214 291 254 258 135 184 148 147 152 160 103 134 120 136 
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Hertfordshire 12 7601 848 523 338 360 324 340 208 247 257 263 180 168 134 148 165 161 102 122 114 130 
Oxfordshire 12 7494 752 470 302 347 285 340 241 280 265 248 201 205 153 128 150 161 118 131 121 136 
Kingston upon 
Thames 11 7196 830 501 293 297 311 335 265 300 210 227 172 233 120 53 138 137 132 111 107 129 
South 
Gloucestershire 11 7389 818 478 285 321 251 343 224 282 244 229 158 245 159 87 131 144 108 137 136 153 
Bracknell Forest 10 7596 811 562 327 365 339 349 244 192 239 246 157 225 167 43 147 171 119 129 123 129 
Buckinghamshire 10 7384 773 418 282 327 274 337 213 292 240 254 229 220 158 133 155 160 103 134 108 139 
Richmond upon 
Thames 10 6734 671 453 284 242 253 327 283 272 207 216 173 180 118 83 127 129 140 107 101 117 
Rutland 10 8131 1037 425 341 389 263 342 209 266 215 313 274 303 175 114 141 98 100 164 85 103 
West Berkshire 10 7780 793 513 329 375 306 343 288 306 283 255 158 236 165 23 150 172 140 144 131 150 
Surrey 9 7154 722 449 284 335 313 340 223 262 247 243 169 192 131 104 149 155 109 120 112 134 
Windsor and 
Maidenhead 9 7748 904 522 306 385 351 345 271 330 266 245 204 135 172 54 144 156 133 121 120 137 
Wokingham 6 6888 723 406 261 321 297 342 213 293 239 200 213 170 142 47 120 136 104 129 114 135 
 
  
Significantly lower than England mean 
(95%UI) 
  
Significantly higher than England mean 
(95%UI) 
 
 
 
  
CONFIDENTIAL pre publication draft. Please do not cite or circulate 
28 
Figure 5. Age-standardised years lived with disability (YLDs) rate per 100,000 population for the 20 causes with the highest national YLD burden in order of 
decreasing burden, in the 15 (10%) most deprived and 15 (10%) least deprived Upper Tier Local Authorities (UTLAs) in England, both sexes, 2016 
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Most deprived 15 UTLAs                       
Blackpool 42 11300 1820 1019 718 661 695 436 459 356 359 291 343 243 206 177 155 152 141 132 131 125 
Kingston upon Hull, City of 41 11075 1819 1029 714 661 674 434 372 356 353 308 254 222 208 176 160 149 142 136 131 119 
Knowsley 41 11165 1835 1037 732 668 666 442 394 354 348 298 312 221 210 179 159 144 140 132 131 99 
Liverpool 41 11133 1822 1041 716 657 660 346 413 353 346 309 388 226 209 178 143 146 142 134 131 111 
Manchester 41 11280 1816 1050 711 659 634 433 439 351 353 292 356 237 207 177 161 156 142 133 131 131 
Middlesbrough 40 11142 1825 1029 720 663 679 436 381 359 349 342 254 234 208 184 158 149 141 133 131 110 
Birmingham 38 11141 1823 1035 720 664 667 437 420 354 344 298 347 241 211 174 160 144 141 135 131 105 
Nottingham 37 11182 1819 1041 711 661 766 433 381 356 347 310 259 240 208 176 166 149 142 135 131 132 
Tower Hamlets 36 11156 1795 1071 704 657 592 430 366 347 391 337 325 266 209 173 171 154 143 137 131 121 
Barking and Dagenham 35 11183 1816 1112 725 666 687 438 351 355 378 325 245 214 211 175 159 131 141 149 131 111 
Hackney 35 11331 1806 1082 718 663 584 436 372 346 391 362 328 288 208 174 174 161 141 134 131 124 
Sandwell 35 11146 1821 1023 719 664 685 436 385 356 350 311 303 252 210 174 159 146 141 135 131 116 
Blackburn with Darwen 34 11139 1822 1023 718 662 685 435 375 358 351 345 329 230 207 178 158 149 141 134 131 99 
Rochdale 34 11170 1825 1022 722 664 695 437 368 356 349 317 315 231 208 178 157 147 141 134 131 117 
Stoke-on-Trent 34 11176 1817 1026 715 661 677 435 471 354 346 327 351 212 207 174 159 142 142 135 131 113 
England 
(95% uncertainty interval) NA 
11054 
(8211-
14261) 
1820 
(1277-
2387) 
1043 
(705-
1482) 
719 
(463-
1007) 
664 
(454-
910) 
667 
(462-
922) 
435 
(304-
591) 
364 
(247-
509) 
355 
(217-
551) 
348 
(228-
499) 
323 
(216-
461) 
276 
(200-
356) 
215 
(146-
300) 
211 
(131-
313) 
176 
(116-
254) 
161 
(120-
201) 
139 
(99-
176) 
141 
(96-
202) 
137 
(93-
192) 
131 
(78-
203) 
127 
(87-
178) 
Least deprived 15 UTLAs                       
Bath and North East Somerset 12 10990 1821 1044 719 666 663 436 351 355 334 399 220 203 214 174 163 135 141 140 132 146 
Central Bedfordshire 12 10948 1819 1034 721 665 673 436 347 354 339 303 248 215 212 177 162 133 141 139 131 140 
Hampshire 12 10966 1820 1041 722 666 654 437 359 353 355 305 258 203 213 175 164 135 141 139 132 135 
Hertfordshire 12 10956 1822 1047 723 667 645 438 350 354 338 301 263 205 214 177 164 137 141 139 132 139 
Oxfordshire 12 10987 1815 1132 716 664 642 435 351 354 335 318 254 213 212 175 137 135 142 154 131 140 
Kingston upon Thames 11 10944 1812 1053 721 666 650 438 333 354 380 333 247 193 215 174 164 130 141 139 132 117 
South Gloucestershire 11 10934 1819 1046 718 665 638 436 343 356 335 390 215 202 212 174 165 135 142 141 131 119 
Bracknell Forest 10 10926 1818 1049 722 666 636 437 370 356 337 288 230 206 214 175 165 138 141 139 132 130 
Buckinghamshire 10 10983 1821 1044 723 667 648 437 365 355 336 298 247 200 213 175 164 134 141 139 132 143 
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Richmond upon Thames 10 10988 1817 1060 726 668 645 440 345 354 378 344 249 194 216 175 164 126 141 138 132 132 
Rutland 10 11006 1814 1019 703 657 679 429 390 357 336 285 259 182 211 177 162 138 143 143 131 156 
West Berkshire 10 10929 1817 1049 720 666 623 436 359 355 342 311 230 217 213 175 167 143 142 140 132 140 
Surrey 9 10960 1819 1093 721 666 639 437 347 354 335 314 242 196 213 175 165 135 141 140 132 126 
Windsor and Maidenhead 9 10876 1819 1054 720 665 627 436 360 357 338 297 232 207 214 175 166 142 142 140 132 132 
Wokingham 6 10887 1819 1051 722 668 637 437 367 354 336 291 228 202 217 175 166 136 141 141 132 133 
 
Note: no estimates are statistically significantly different from the England mean 
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Figure 6: Attributable risk for age-standardised all-cause years of life lost (YLLs) rate per 100,000 1 
population for nine major risk factors, and Upper Tier Local Authority (UTLA) level Index of Multiple 2 
Deprivation (IMD) Score, for UTLAs in three regions of England, 2016 3 
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Figure 7: Life expectancy at birth for England, Scotland, Wales, and Northern Ireland between 1990 1 
and 2016, men and women 2 
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Figure 8. Annual percentage change and 95% uncertainty range in years of life lost (YLLs) rate per 1 
100,000 population for the nine causes with the highest national burden, from 1990 to 2016 in 2 
England, with the percentage that each condition contributes to all-cause YLLs in brackets. 3 
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 5 
 6 
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